Related Experiment Video
Updated: Oct 18, 2025
12:45
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
5.9K
Update on Robotic Total Mesorectal Excision for Rectal Cancer
Simona Giuratrabocchetta1, Giampaolo Formisano1, Adelona Salaj1
1Division of General and Robotic Surgery, Dipartimento di Scienze della Salute, Università di Milano, ASST Santi Paolo e Carlo, 20142 Milano, Italy.
Journal of Personalized Medicine
|September 28, 2021
Summary
Robotic surgery for rectal cancer offers potential benefits over traditional methods, including fewer complications and shorter hospital stays. Further research is needed to confirm its advantages in complex cases.
Area of Science:
- Surgical Oncology
- Minimally Invasive Surgery
- Robotic Surgery
Background:
- Total Mesorectal Excision (TME) for rectal cancer is technically demanding, with potential impacts on patient outcomes.
- Laparoscopic versus open surgery results are conflicting; trans-anal approaches are emerging.
- Robotic surgery offers enhanced dexterity for minimally invasive procedures in confined spaces like the pelvis.
Purpose of the Study:
- To evaluate the potential benefits of robotic surgery in minimally invasive rectal cancer treatment.
- To compare robotic TME with laparoscopic and open approaches.
- To assess the impact of robotic surgery on oncological and functional outcomes.
Main Methods:
- Review of population-based multicenter studies comparing robotic and laparoscopic TME.
- Analysis of data on conversion rates, complication rates, and length of stay.
- Consideration of direct and indirect costs associated with robotic surgery.
Main Results:
- Robotic surgery may reduce conversion rates and complications compared to laparoscopy.
- Shorter length of stay has been observed with robotic TME.
- Cost-effectiveness requires evaluation of both direct and indirect expenses.
Conclusions:
- Robotic surgery shows promise for improving outcomes in minimally invasive rectal cancer treatment.
- Further prospective and randomized data are necessary to fully establish its advantages, particularly in complex patient subsets.
- Comprehensive cost-benefit analysis is crucial for widespread adoption.
